Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV-1 reverse transcriptase: a therapeutical target in the spotlight.

H C Castro1, N I V Loureiro, M Pujol-Luz

  • 1Laboratório de Bioquímica e Modelagem Molecular (LaBioMol), Departamento de Biologia Celular e Molecular, IB, Universidade Federal Fluminense (UFF), Outeiro Sao Joao Batista, Niterói, RJ, 24001-970, Brazil. hcastrorangel@yahoo.com.br

Current Medicinal Chemistry
|February 16, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of inhaled moxifloxacin-metformin formulation as an alternative for pulmonary tuberculosis treatment.

International journal of pharmaceutics·2024
Same author

Structure-activity relationship, molecular docking, and molecular dynamic studies of diterpenes from marine natural products with anti-HIV activity.

Journal of biomolecular structure & dynamics·2020
Same author

A rhamnose-binding lectin from Rhodnius prolixus and the impact of its silencing on gut bacterial microbiota and Trypanosoma cruzi.

Developmental and comparative immunology·2020
Same author

8-Hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into murine Macrophages.

Bioorganic & medicinal chemistry·2018
Same author

1,4-Naphthoquinones potently inhibiting P2X7 receptor activity.

European journal of medicinal chemistry·2017
Same author

A Promising Antiprion Trimethoxychalcone Binds to the Globular Domain of the Cellular Prion Protein and Changes Its Cellular Location.

Antimicrobial agents and chemotherapy·2017

Human Immunodeficiency Virus type 1 Reverse Transcriptase (HIV-1 RT) is a key target for AIDS treatment. Understanding its structure and mutations is crucial for developing new drugs against resistant strains.

Area of Science:

  • Biochemistry
  • Virology
  • Drug Discovery

Background:

  • Human Immunodeficiency Virus type 1 Reverse Transcriptase (HIV-1 RT) is essential for viral replication, catalyzing the conversion of HIV-RNA to DNA.
  • Current antiretroviral therapies target HIV-1 RT, but drug resistance emerges due to mutations.
  • HIV-1 RT remains a critical and cost-effective target for developing novel antiviral agents.

Purpose of the Study:

  • To review the structural characteristics of HIV-1 RT.
  • To discuss the mechanisms of action and development of HIV-1 RT inhibitors.
  • To highlight HIV-1 RT as a vital target for new antiretroviral drug development.

Main Methods:

  • Literature review of structural biology studies on HIV-1 RT.
  • Analysis of structure-activity relationships for HIV-1 RT inhibitors.

Related Experiment Videos

  • Examination of mutation-induced drug resistance mechanisms.

    • Main Results:

    • Detailed insights into the structural features of HIV-1 RT.
    • Understanding of how substrate specificity and catalytic mechanisms inform inhibitor design.
    • Identification of challenges posed by drug-resistant mutations.

    Conclusions:

    • HIV-1 RT's structure and function provide a foundation for rational drug design.
    • Continued research into HIV-1 RT is essential for overcoming drug resistance.
    • HIV-1 RT remains a promising and cost-effective target for future AIDS therapies.